WebMD isn’t entirely without value, but it has real credibility problems that range from how it makes money to how accurately it identifies what’s wrong with you. The site is owned by a private equity firm, funded heavily by pharmaceutical advertising, and uses symptom-checking tools that get the right diagnosis as a first result only about a third of the time. None of that makes it useless, but it does mean you should understand its limitations before trusting it with your health decisions.
Symptom Checkers Get It Wrong More Often Than Right
The most direct credibility issue is accuracy. A large audit published in The BMJ evaluated 23 online symptom checkers, including the type WebMD offers, and found they listed the correct diagnosis first only 34% of the time. Even when the tools were given 20 chances to name the right condition, they still only succeeded 58% of the time. For comparison, physicians are estimated to diagnose correctly 85% to 90% of the time.
Triage advice, meaning whether the tool correctly told users to seek emergency care, see a doctor soon, or manage symptoms at home, was appropriate in just 57% of cases. That means roughly four out of ten times, the tool either overreacted or underreacted to the situation. When you’re trying to figure out if a symptom is serious, a coin-flip level of accuracy isn’t reassuring.
The Advertising Model Creates Built-In Bias
WebMD generates revenue primarily through advertising, and a large share of that comes from pharmaceutical companies. The U.S. pharmaceutical industry spends more than $6 billion annually on direct-to-consumer advertising, and health websites are a major channel for that spending. This creates an environment where the content you read sits alongside, and sometimes blends with, ads for the very medications discussed in articles about your symptoms.
This matters because studies show direct-to-consumer drug advertising increases demand for medications and prompts more doctor visits and diagnoses. A health economist studying the effects of these policies has noted that the practice can steer patients toward heavily marketed brands instead of the most appropriate treatment. WebMD has disclosed in SEC filings that the sale of advertising and sponsorships to healthcare providers on web-based health services like theirs has even drawn scrutiny under federal anti-kickback law. A 2002 advisory opinion from the Office of the Inspector General concluded that such arrangements implicate the law, though enforcement would be unlikely as long as fees represent fair market value and sponsorship relationships are clearly identified to users.
The question isn’t whether WebMD publishes outright false information on behalf of advertisers. It’s subtler than that. When a site’s revenue depends on pharmaceutical companies, the selection of topics, the prominence given to drug-based treatments, and the framing of conditions can all tilt in ways that serve advertisers’ interests without technically being inaccurate.
Private Equity Ownership Shapes Priorities
WebMD was acquired in 2017 by an entity controlled by KKR, one of the world’s largest private equity firms, through a subsidiary called MH Sub I, LLC. Private equity firms acquire companies to generate returns for investors, typically on a timeline of several years. That doesn’t mean the content is automatically compromised, but it does mean the organization’s primary obligation is to its investors, not to public health. Decisions about what content to produce, how aggressively to monetize traffic, and how much to invest in editorial rigor are filtered through a profit-maximization lens.
Search Results Favor Scary Diagnoses
One of the most consistent complaints about WebMD is that searching a common symptom like a headache seems to lead straight to brain tumors or other frightening conditions. This isn’t paranoia. Research from Microsoft has demonstrated exactly how this happens.
When researchers analyzed co-occurrence statistics in top-ranked web search results, they found that “brain tumor” appeared alongside “headache” 26% of the time, more than eight times the rate found in broader web content and vastly higher than the actual incidence of brain tumors. Similarly, “heart attack” co-occurred with “chest pain” in 37% of top-ranked search content, compared to 15% across the wider web. Health websites like WebMD both contribute to and benefit from this pattern, because alarming content attracts more clicks, and more clicks push that content higher in search rankings.
Search engines aren’t designed to perform diagnostic reasoning. They rank pages based on relevance signals and popularity, not on how likely a condition actually is given your symptoms. The result is a self-reinforcing cycle: anxious users click on worst-case scenarios, which tells the algorithm those results are useful, which pushes them higher for the next person searching the same symptom.
The Anxiety Spiral Is Well Documented
Reading WebMD doesn’t just give you potentially inaccurate information. It can actively make you feel worse. Researchers have identified a behavioral pattern called cyberchondria: excessive or compulsive online searching for health information that leads to increased anxiety rather than relief.
The mechanism is straightforward. As you search for symptoms, you encounter worst-case scenarios and conflicting information. The sheer volume of health content online makes it difficult to evaluate what’s actually relevant to your situation, which increases the likelihood of misinterpretation and catastrophic thinking. That anxiety then drives more searching, which produces more alarming results, which deepens the anxiety. Studies have confirmed that the frequency of online health searching predicts higher health anxiety scores: the more you search, the more anxious you become.
WebMD’s format is particularly well-suited to triggering this cycle. Symptom pages typically list multiple possible conditions ranging from benign to life-threatening, without giving you a meaningful way to assess probability. A page about chest pain might list heartburn and heart attack side by side, and without clinical context, many readers fixate on the worst possibility. Seeking to diagnose your own symptoms online increases the likelihood of noticing and misinterpreting harmless sensations as evidence of disease.
The Editorial Process Has Limits
WebMD does employ medical reviewers, and its editorial process requires at least two clinical reviewers for content, with at least one being a specialist in the relevant area. The company verifies that reviewers hold active, unencumbered clinical licenses and re-checks credentials every one to two years. This is more rigorous than many health websites.
But editorial review doesn’t eliminate the structural problems. Reviewed content can still be selected and framed to align with advertiser interests. A medically accurate article can still be misleading if it emphasizes drug treatments over lifestyle changes, or if it’s positioned next to a sponsored module for a related medication. The review process ensures factual correctness at the sentence level without necessarily addressing the broader editorial choices about what gets covered, how prominently, and in what context.
How WebMD Compares to Other Sources
National survey data from the Health Information National Trends Survey shows that about 55% of Americans report “some” or “a lot” of trust in health information found on the internet, compared to nearly 71% who trust government health agencies. That gap reflects a reasonable instinct. Government sources like the CDC, NIH, and MedlinePlus operate without advertising revenue, have no pharmaceutical sponsors, and exist specifically to inform the public rather than to generate profit.
WebMD occupies a middle ground. Its content is generally reviewed by credentialed professionals, which puts it above random blog posts or social media health advice. But its business model, ownership structure, and the inherent limitations of symptom-checking algorithms place it well below peer-reviewed medical literature or government health agencies. It’s a starting point at best, not a reliable endpoint for making health decisions.